We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Applied DNA Sciences is seeking an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its Linea 2.0 Covid-19 assay and Linea unsupervised at-home
Altasciences is pleased to have been chosen by Virpax® Pharmaceuticals, Inc. (“Virpax”) (NASDAQ:VRPX) to conduct a first-in-human study of Epoladerm (diclofenac epolamine) for chronic pain associated with osteoarthritis
Leading health tech firm Qure.ai has gained 510(k) clearance from the Food and Drug Administration (FDA) for an artificial intelligence (AI) algorithm called qXR-BT, that will help doctors
Probo Medical, a provider of refurbished diagnostic imaging equipment, has wrapped the acquisition of Remetronix for an undisclosed sum. Based in Port St. Lucie of Florida, Remetronix provides
Cardiovascular Systems (CSI) and OrbusNeich Medical have announced premarket approval (PMA) from the US FDA for the Scoreflex scoring balloon. OrbusNeich’s Scoreflex NC scoring percutaneous transluminal coronary angioplasty
Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, announced today the upcoming launch of the Allplex™ SARS-CoV-2 Fast PCR Assay, which can deliver PCR results in
Stryker, one of the world’s leading medical technology companies, announced today that its new Tornier Perform® Patient-Matched Primary Reversed Glenoid (Patient-Matched Glenoid) was used in a surgical procedure
The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) approval for Capillary Biomedical (CapBio) to begin a pivotal trial of its SteadiFlow seven-day-wear
Pathogen diagnostic company Pathogenomix has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its Patho-Seq assay. Patho-Seq has been developed for the detection
Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today announced initiation of its second clinical study investigating the extension of the company’s